News

Filter

Current filters:

Merck & Co

151 to 160 of 97540 results

Mersana Therapeutics in up to $300 million deal with Takeda

13-01-2015

Privately-held US biotech company Mersana Therapeutics has expanded its ongoing collaboration with Japan’s…

BiotechnologyLicensingMersana TherapeuticsOncologyTakeda Pharmaceutical

Vedanta collaborates with Janssen on IBD drug candidate VE202

13-01-2015

US microbiome company Vedanta Biosciences has signed a license agreement with Janssen Biotech for Vedanta's…

BiotechnologyGastro-intestinalsJanssen BiotechJohnson & JohnsonLicensingResearchVE202Vedanta Biosciences

Ukraine on verge of new increase in drug prices

13-01-2015

Ukraine is on the verge of a new increase of pharmaceutical prices and a potential shortage of drugs,…

PharmaceuticalPoliticsPricingUkraine

Amgen to collaborate with University of Texas on BiTE technology

Amgen to collaborate with University of Texas on BiTE technology

13-01-2015

US biotech major Amgen is to collaborate with the MD Anderson Cancer Center at the University of Texas…

AmgenBiotechnologyOncologyResearchUSA

New drugs and biosimilars to drive rheumatoid arthritis to $19.3 billion by 2023

New drugs and biosimilars to drive rheumatoid arthritis to $19.3 billion by 2023

13-01-2015

The launch of novel drugs and biosimilars will drive steady growth in the global rheumatoid arthritis…

AmgenAnti-Arthritics/RheumaticsEnbrelHumiraMarkets & MarketingPharmaceuticalResearchUSA

Merck & Co updates on plans to accelerate new drug submissions and future growth

Merck & Co updates on plans to accelerate new drug submissions and future growth

13-01-2015

US pharma giant Merck & Co has reported on the ongoing execution of its multi-year, strategic initiative…

Anti-viralsgrazoprevir/elbasvirKeytrudaMerck & CoOncologyPharmaceuticalRegulationResearchUSA

Harvoni scores another victory with inclusion on Prime’s preferred list

Harvoni scores another victory with inclusion on Prime’s preferred list

13-01-2015

US pharmacy Prime Therapeutics has agreed to provide hepatitis C drug Harvoni (ledipasvir/sofosbuvir)…

Antibiotics and Infectious diseasesBiotechnologyGileadHarvoniPricingUSA

Debiopharm regains rights to alisporivir in hepatitis C from Novartis

Debiopharm regains rights to alisporivir in hepatitis C from Novartis

13-01-2015

Switzerland-based biopharma company Debiopharm has updated its arrangement with Novartis to regain full…

alisporivirDebiopharmLicensingNephrology and HepatologyNovartisPharmaceuticalResearch

151 to 160 of 97540 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top